532834 Stock Overview
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Camlin Fine Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹111.22 |
| 52 Week High | ₹186.25 |
| 52 Week Low | ₹88.45 |
| Beta | 0.99 |
| 1 Month Change | 13.09% |
| 3 Month Change | -13.41% |
| 1 Year Change | -35.93% |
| 3 Year Change | -26.85% |
| 5 Year Change | 142.31% |
| Change since IPO | 1,208.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532834 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 3.6% | 1.9% | 1.4% |
| 1Y | -35.9% | 18.9% | 46.1% |
Return vs Industry: 532834 underperformed the Indian Chemicals industry which returned 16.5% over the past year.
Return vs Market: 532834 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 532834 volatility | |
|---|---|
| 532834 Average Weekly Movement | 7.4% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532834 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532834's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1931 | 627 | n/a | www.camlinfs.com |
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; pharmaceutical and nutraceutical products from fermentation and plant extraction sources; and performance chemicals, such as hydroquinone and catechol.
Camlin Fine Sciences Limited Fundamentals Summary
| 532834 fundamental statistics | |
|---|---|
| Market cap | ₹18.63b |
| Earnings (TTM) | -₹8.31m |
| Revenue (TTM) | ₹16.38b |
1.1x
P/S Ratio-2,242x
P/E RatioIs 532834 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532834 income statement (TTM) | |
|---|---|
| Revenue | ₹16.38b |
| Cost of Revenue | ₹8.94b |
| Gross Profit | ₹7.44b |
| Other Expenses | ₹7.45b |
| Earnings | -₹8.31m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.05 |
| Gross Margin | 45.43% |
| Net Profit Margin | -0.051% |
| Debt/Equity Ratio | 73.5% |
How did 532834 perform over the long term?
See historical performance and comparison